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Background: Vascular endothelium, a provider of nitric oxide, is essential for the   maintenance 
of homeostasis in healthy vascular systems. Increased oxidative stress promotes vascular 
inflammation and is a common pathway involved in endothelial damage. The present study 
sought to investigate the usefulness of derivative reactive oxygen metabolites (d-ROM) as an 
oxidative stress marker for detecting endothelial damage in the clinical setting in subjects with 
early-stage atherosclerosis.
Methods: Study 1 investigated the relationship between serum d-ROM levels and   cardiovascular 
risk factors in apparently healthy middle-aged subjects (n = 1992, 49 ± 8 years) who participated 
in our health checkup program. Study 2 analyzed the association between d-ROM levels and 
endothelial function assessed by flow-mediated dilation and that between d-ROM levels and high-
sensitivity C reactive protein (hs-CRP) levels in middle-aged outpatients with mild-to-moderate 
cardiovascular risk (n = 43, 40 ± 5 years).
Results: In study 1, the d-ROM level was independently correlated with age, systolic blood 
pressure, fasting plasma glucose, low-density lipoprotein cholesterol, and brain natriuretic 
peptide in univariate and multivariate regression analysis. In study 2, the d-ROM level was 
correlated positively with the hs-CRP level and inversely with the flow-mediated dilation value. 
Patients in the highest tertile of d-ROM had significantly lower flow-mediated dilation values 
compared with patients in the other tertiles. Moreover, after subdivision of patients into four 
groups according to d-ROM and hs-CRP levels, patients with high levels of both d-ROM and 
hs-CRP showed significantly reduced flow-mediated dilation as compared with those with low 
levels of both indices.
Conclusion: The close relationship of d-ROM with cardiovascular risk factors, brain natriuretic 
peptide, inflammatory markers (hs-CRP), and endothelial function (flow-mediated dilation) 
  suggest that d-ROM is a useful oxidative stress marker for detection of endothelial damage in 
the clinical setting. Assessment of d-ROM, especially combined with hs-CRP, may be a   possible 
predictor of cardiovascular disease.
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Introduction
Cardiovascular disease is a leading cause of mortality and morbidity in most   modern 
societies, with prevention as well as treatment of the condition a focus of recent 
attention.1 Changing lifestyles have highlighted risk factors for cardiovascular disease, 
including hypertension, dyslipidemia, diabetes mellitus, and smoking.1 Because the Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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development of cardiovascular disease is largely based on 
functional and structural changes in systemic vasculature, 
namely atherosclerosis, early detection of such changes is 
an important public health issue.1–3
Atherosclerosis is a chronic inflammatory disease of the 
vascular wall initiated by functional alterations in vascular 
endothelium.2–4 Indeed, endothelial dysfunction in resistance 
vessels, conduit arteries, or coronary arteries independently 
predicts adverse cardiovascular outcomes, strongly   suggesting 
that endothelial dysfunction is a surrogate marker of cardio-
vascular events in addition to systemic vascular damage.5–8 
However, endothelial function cannot be easily assessed 
in a clinical setting because of technical complexity, and 
the assessment is limited mainly to research institutes.9–12 
  Therefore, safe, noninvasive, reproducible, and inexpensive 
modalities are needed to detect and assess endothelial dysfunc-
tion, as an initial step in the process of atherosclerosis.13
The endothelium produces several bioactive molecules, 
which could be antiatherogenic or proatherogenic, and 
homeostasis in a healthy vascular system is maintained by 
the balance between these factors.3,9 Cardiovascular risk 
factors impair this balance through an increase in oxida-
tive stress, leading to vascular inflammation.9,13 Thus, 
  oxidative stress and inflammation are an important part of 
the   endothelial damage process, and laboratory biomarkers 
of these two states are possible candidates for measuring 
endothelial function.9,13,14 As expected, high-sensitivity C 
reactive protein (hs-CRP) is recognized as a reliable predic-
tor of endothelial function and cardiovascular disease.15–17 
In contrast, markers of oxidative stress, such as malondi-
aldehyde-modified low-density lipoprotein, thiobarbituric 
acid reactive substances, and 8-isoprostane have not been 
widely accepted as markers of endothelial function or 
cardiovascular events.16,18,19 Recently, a simple method of 
detecting hydroperoxide levels by measuring derivatives of 
reactive oxygen metabolites (d-ROM) was developed.20–22 
Thus, the present study was designed to test our fundamental 
hypothesis that d-ROM is a useful marker of oxidative stress 
for evaluating cardiovascular risk burden and for detecting 
endothelial damage in the clinical setting.
Methods
The present study comprised two parallel substudies, ie, one 
evaluating the relationship between d-ROM and cardiovas-
cular risk factors in the general population (study 1) and the 
other investigating the impact of markers of oxidative stress 
on endothelial function in subjects with mild-to-moderate 
cardiovascular risk factors (study 2).
Study 1
Middle-aged subjects (aged 20–60 years) who underwent 
health checkups at Enshu Hospital from September 2008 to 
August 2009 were enrolled. In addition to our standard health 
checkup program (an interview regarding health status, rou-
tine physical examination, chest x-ray,   electrocardiography, 
brain natriuretic factor measurement, and laboratory assess-
ment of cardiovascular risk factors), serum levels of d-ROM 
were measured. Subjects with obvious organ damage, a 
complication of malignant neoplasm or active inflamma-
tory disease, and/or a history of cardiovascular events were 
excluded. Current smokers were also excluded, because 
serum reactive oxygen metabolite levels are influenced by 
smoking.23 Blood pressure was measured using a standard 
mercury sphygmomanometer with the subject in the sitting 
position. The relationship between serum reactive oxygen 
metabolites and cardiovascular risk factors was investigated. 
The study protocol was approved by the ethics committee of 
Enshu Hospital, and written informed consent was obtained 
from all subjects before the study commenced.
Study 2
Middle-aged never-treated outpatients who were newly 
diagnosed with hypertension or dyslipidemia at Nagoya 
City   University Hospital from September 2008 to August 
2009, with one or more additional risk factors, includ-
ing   hypertension, dyslipidemia, and smoking, namely 
mild-to-moderate   cardiovascular risk according to the 
guidelines of the Japan Atherosclerosis Society and   Japanese 
  Society of   Hypertension, were enrolled in this second 
study.24,25 Patients with severe cardiovascular risk, obvi-
ous organ damage, diabetes mellitus, a history of cardio-
vascular events, a complication of malignant neoplasm or 
active inflammatory disease, and/or taking any medications 
influencing vascular integrity were excluded. The study 
examination was performed before the start of medication 
and patients who smoked were instructed to stop smoking 
24 hours before the examination. Endothelial function was 
assessed by investigating endothelium-dependent flow-
mediated vasodilation in a fasting condition.12,13 In addition to 
the laboratory measurements including hs-CRP and d-ROM, 
circulating endothelial progenitor cells, which are considered 
to mobilize into the peripheral circulation from the bone 
marrow and play a pivotal role in repairing endothelial dam-
age, were evaluated by measuring CD34-positive progenitor 
cells.26–28 Blood pressure was measured in the nondominant 
arm using a validated oscillometric technique (HEM-7070; 
Omron Corporation, Kyoto, Japan) in a seated position. Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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Relationships between serum reactive oxygen metabolites 
and flow-mediated dilation values, hs-CRP, and the number 
of circulating endothelial progenitor cells were investigated. 
The study protocol was approved by the ethics committee 
of Nagoya City University Graduate School of Medical 
  Sciences, and written informed consent was obtained from 
each subject prior to starting the study.
Biochemical analysis
Serum total cholesterol, low-density lipoprotein   cholesterol, 
high-density lipoprotein cholesterol, and triglyceride   levels 
were determined by standard laboratory assays. Brain 
natriuretic peptide was measured by radioimmunoassay 
(Shionoria BNP kit, Shionogi, Osaka, Japan). Hs-CRP was 
determined by latex-enhanced immunonephelometry on a 
BN II analyzer (Dade Behring, Marburg, Germany).
The d-ROM level was measured as previous reported.20–22 
Briefly, serum sample and acidic buffered solution (R2 kit 
reagent, pH 4.8) were mixed in a cuvette, and a chromoge-
nic substrate (R1 kit reagent) was then added to the cuvette. 
After mixing well, the cuvette was immediately incubated in 
the thermostatic block of the analyzer for five minutes, and 
then absorbance at 505 nm was recorded. Measurements are 
expressed as arbitrary units (Carr). This method spectropho-
tometrically detects the oxidization of N,N-diethyl-para-
  phenylenediamine by radicals converted from hydroperoxides. 
The intra-assay and interassay coefficients of variation for 
d-ROM were 3.2% and 3.6%, respectively, and the analytical 
range was 50–500 Carr. The normal reference level indicated 
by the manufacturer is 250–300 Carr.
Circulating CD34-positive mononuclear cells, one form 
of circulating endothelial progenitor cells, were defined as 
CD34+ progenitor cells and quantified by flow cytometry as 
described previously.26 In detail, 4 mL of peripheral blood 
was drawn and white blood cells were stained with peridinin 
chlorophyll-a protein-conjugated anti-CD45 monoclonal 
antibody (Becton Dickinson, Franklin Lakes, NJ) and fluo-
rescein isothiocyanate-conjugated anti-CD34 monoclonal 
antibody (IOTest; Beckman Coulter, Tokyo, Japan). Samples 
were subjected to two-dimensional side scatter-fluorescence 
dot plot analysis (FACScan). After appropriate gating with 
low cytoplasmic granularity and low expression of CD45, 
the number of CD34+ progenitor cells was quantified and 
expressed as number of cells per 106 total events.
Determination of endothelial function
The flow-mediated dilation technique is a noninva-
sive method for assessment of endothelial function.24 
  Flow-mediated dilation was measured using high resolution 
ultrasound apparatus with a 7.5 mHz linear array transducer 
(ProSound SSD-6500SV; Aloka Co Ltd, Tokyo, Japan) 
equipped with an ECG-gated computer system having 
automatic edge detection software (e-Tracking system, 
Aloka Co Ltd, Tokyo, Japan) according to the guidelines of 
the International   Brachial Artery Reactivity Task Force.12,13 
Endothelial function was measured in the supine position 
with the brachial artery diameter of the nondominant arm at 
5 cm above the elbow in a dark, quiet, and air-conditioned 
room (22°C–25°C). The longitudinal image of the brachial 
artery was continuously recorded throughout the measure-
ments. The e-Tracking system enables continuous and 
stable image acquisition. Baseline data was recorded for 
one minute after 15 minutes of supine rest and a sphygmo-
manometric cuff placed around the forearm distal to the 
cubital fossa was then inflated to up to either 200 mmHg 
or 50 mmHg above each subject’s systolic blood pressure 
to occlude arterial inflow. After a period of five minutes, 
subsequent cuff deflation causes dilation of brachial artery 
by an increase in shear stress. The diameter of the brachial 
artery was continuously recorded for five minutes, and 
flow-mediated dilation was automatically calculated as 
percent change in peak vessel diameter from the baseline. 
With 15 minutes of rest after acquisition of endothelium-
dependent vasodilation, this parameter was subsequently 
quantified. After acquisition of baseline data for one minute, 
0.15 mg of glyceryl trinitrate (NitropenTM; Nihonkayaku, 
Tokyo, Japan) was administered sublingually and the diam-
eter of the brachial artery was continuously recorded for 
five minutes and analyzed by a similar method. The intraob-
server coefficient of variation for the baseline diameter was 
2.5%. All subjects were examined by a single cardiologist. 
Both flow-mediated dilation and glyceryl trinitrate-induced 
endothelium-independent dilation were expressed as the 
percent change from baseline.
Statistical analysis
Data were analyzed using StatView 5.0 (SAS Institute, Cary, 
NC) and expressed as means ± standard deviation. Urinary 
albumin was expressed as urinary albumin to creatinine ratio 
(mg/g creatinine). Because urinary albumin to creatinine ratio, 
brain natriuretic peptide, and hs-CRP did not show a normal 
distribution, the value was analyzed after log-  transformation. 
The dichotomous variables (gender and smoking status) were 
assigned values of 0 (female and nonsmoking) and 1 (male 
and smoking). Univariate and multivariate linear regression 
analyses associated with d-ROM level or flow-mediated Vascular Health and Risk Management 2011:7
Table 1 characteristics of subjects and results of univariate regression analysis demonstrating the relationship of variables with 
d-ROM in study 1
Variable Total subjects (n = 1992) Coefficient (r) P value
Age (years) 49 ± 8 0.17 ,0.0001
gender, male (%) 800 (40) -0.32 ,0.0001
BMi (kg/m2) 22.4 ± 3.2 0.038 0.088
Systolic BP (mmHg) 122 ± 15 0.079 ,0.001
Diastolic BP (mmHg) 75 ± 10 0.029 0.19
Hemoglobin (g/dL) 13.8 ± 1.2 -0.22 ,0.0001
creatinine (mg/dL) 0.72 ± 0.15 -0.25 ,0.0001
UAcR (mg/g creatinine) 6.5 ± 22.5 0.098 ,0.0001
Uric acid (mg/dL) 5.0 ± 1.3 -0.15 ,0.0001
FPg (mg/dL) 95 ± 15 0.055 ,0.05
Total c (mg/dL) 211 ± 33 0.112 ,0.0001
LDL-c (mg/dL) 122 ± 29 0.096 ,0.0001
HDL-c (mg/dL) 63 ± 14 0.087 ,0.0001
Triglycerides (mg/dL) 98 ± 60 -0.029 0.20
BnP (pg/mL) 13.8 ± 14.3 0.059 ,0.05
d-ROM (carr) 320 ± 61 – –
Note: Data are expressed as means ± standard deviation.
Abbreviations: d-ROM, derivative reactive oxygen metabolites; BMi, body mass index, BP; blood pressure; UAcR, urinary albumin to creatinine ratio; FPg, fasting plasma 
glucose; total c, total cholesterol; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; BnP, brain natriuretic peptide.
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dilation values were performed. Comparisons among mul-
tiple subgroups were performed using one-way analysis of 
variance followed by Bonferroni’s post hoc test. Statistical 
significance was set at P , 0.05.
Results
Study 1
Table 1 details the characteristics of subjects in study 1. 
The mean age was 49 years and the mean blood pressure 
was 122/75 mmHg. There were 226 (11%), 756 (38%), 
and 86 (4%) subjects with hypertension, dyslipidemia, 
and diabetes mellitus, respectively, indicating that the 
study subjects represented a general population. The 
d-ROM value in subjects without cardiovascular risk was 
298 ± 50 Carr. In addition to known cardiovascular risk 
parameters (age, gender, systolic blood pressure, hemo-
globin, creatinine, fasting plasma glucose, uric acid, and 
lipid parameters [total cholesterol, low-density lipoprotein 
cholesterol, and high-density lipoprotein cholesterol]), 
brain natriuretic peptide showed significant correlations 
with d-ROM by univariate regression analysis (r = 0.059, 
P , 0.05, Table 1). Multivariate regression analysis 
showed that d-ROM was independently associated with 
age (P , 0.001), gender (P , 0.0001), systolic blood 
pressure (P , 0.05), fasting plasma glucose (P , 0.05), 
low-density lipoprotein cholesterol ( P , 0.05), and brain 
natriuretic peptide (P , 0.05, Table 2).
Study 2
To evaluate a possible association of d-ROM with endothelial 
function, flow-mediated dilation values, CD34+ progenitor 
cell number, and hs-CRP levels were assessed in subjects 
with mild-to-moderate risk. Characteristics of 43 patients 
involved in this series of the study are shown in Table 3. 
The mean age was 40 years and the mean d-ROM level 
was 314 Carr, which was younger and lower, respectively, 
than subjects in Study 1. In subjects with mild-to-moderate 
risk, the d-ROM level correlated significantly with hs-CRP 
  levels (r = 0.37, P , 0.05) and flow-mediated dilation values 
(r = -0.40, P , 0.01), but not with the CD34+ progenitor 
cell number or glyceryl trinitrate-induced endothelium-
independent dilation values (Figure 1). To confirm the impact 
of d-ROM on hs-CRP and flow-mediated dilation, patients 
were divided into tertiles according to d-ROM levels (  cut 
off levels 295 and 335 Carr). Patients in the highest tertile 
(.335 Carr) had a significantly increased hs-CRP level and 
a reduced flow-mediated dilation value compared with those 
in the lowest tertile (P , 0.05, Figure 2).
In a separate analysis, patients were divided into four 
subgroups according to d-ROM and hs-CRP levels to 
compare the impact of oxidative stress markers and inflam-
mation status on flow-mediated dilation. The mean value 
of d-ROM (316 Carr) and the hs-CRP value (0.50 mg/L) 
corresponding to the mean log (hs-CRP) value were used as 
cutoff values. This analysis revealed that the flow-mediated Vascular Health and Risk Management 2011:7
Table 2 Multivariate regression analysis demonstrating factors associated with d-ROM in study 1
Variables β SE Standardized coefficient P
Age (years) 0.70 0.18 0.096 ,0.001
BMi (kg/m2) 0.80 0.51 0.044 0.099
gender male -39 5.3 -0.31 ,0.0001
Systolic BP (mmHg) 0.24 0.10 0.060 ,0.05
Hemoglobin (g/dL) -0.95 1.8 -0.018 0.60
creatinine (mg/dL) -12 13 -0.031 0.35
UAcR (mg/g creatinine) 2.8 3.6 0.017 0.45
Uric acid (mg/dL) 1.8 1.4 0.038 0.20
FPg (mg/dL) 0.20 0.096 0.050 ,0.05
LDL-c (mg/dL) 0.11 0.052 0.050 ,0.05
HDL-c (mg/dL) 0.17 0.11 0.039 0.13
Triglycerides (mg/dL) 0.016 0.028 0.015 0.55
BnP (pg/mL) -11 5.7 -0.048 ,0.05
Abbreviations: Se, standard error; d-ROM, derivative reactive oxygen metabolites; BMi, body mass index; BP, blood pressure; UAcR, urinary albumin to creatinine ratio; 
FPg, fasting plasma glucose; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; BnP, brain natriuretic peptide.
Table 3 characteristics of patients enrolled in study 2 and correlation of factors associated with FMD
Variable Total patients (n = 43) Coefficient (r) P value
Age (years) 40 ± 5 -0.31 ,0.05
BMi (kg/m2) 24.5 ± 3.4 -0.21 0.19
gender male (%) 39 (91%) 0.28 0.07
Smoking status (%) 11 (26%) -0.36 ,0.05
Systolic BP (mmHg) 134 ± 12 -0.22 0.17
Diastolic BP (mmHg) 86 ± 9 -0.10 0.55
Hemoglobin (g/dL) 15.3 ± 1.1 -0.094 0.56
creatinine (mg/dL) 0.77 ± 0.13 -0.010 0.95
FPg (mg/dL) 96 ± 7 -0.27 0.25
HbA1c (%) 5.0 ± 0.5 -0.19 0.45
Total c (mg/dL) 205 ± 33 -0.091 0.57
LDL-c (mg/dL) 122 ± 29 -0.11 0.48
HDL-c (mg/dL) 55 ± 12 0.37 ,0.05
Triglycerides (mg/dL) 153 ± 93 -0.40 ,0.01
hs-cRP (mg/L) 0.87 ± 1.1 -0.34 ,0.05
d-ROM (carr) 316 ± 45 -0.42 ,0.01
cD34+ Pc (106/cells) 326 ± 172 0.32 ,0.05
FMD (%) 4.0 ± 1.7 – –
gTD (%) 15.6 ± 5.3 – –
Note: Data are expressed as means ± standard deviation.
Abbreviations: FMD, flow-mediated dilation; BMI, body mass index; BP, blood pressure; FPG, fasting plasma glucose; total C, total cholesterol; LDL-C, low-density 
lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; hs-cRP, high-sensitivity c reactive protein; d-ROM, derivative reactive oxygen metabolites; cD34+ Pc, 
cD34-positive progenitor cells; gTD, glyceryl trinitrate-induced dilation.
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dilation value was significantly reduced in the subgroup 
with higher levels of both d-ROM and hs-CRP than in the 
subgroup with lower levels of both d-ROM and hs-CRP 
(P , 0.05, Figure 3).
Table 3 indicates the relationships between the flow-
mediated dilation value and other parameters. The flow-
mediated dilation value was correlated inversely with age 
(r = -0.31, P , 0.01), smoking status (r = -0.36, P , 0.05), 
triglycerides (r = -0.40, P , 0.01), hs-CRP (r = -0.34, 
P , 0.05), and d-ROM (r = -0.42, P , 0.01), and positively 
with high-density lipoprotein cholesterol (r = 0.37, P , 0.05) 
and CD34+ progenitor cells (r = 0.32, P , 0.05).
Discussion
The present study revealed that classical cardiovascular 
risk parameters (age, systolic blood pressure, fasting 
plasma   glucose, and low-density lipoprotein cholesterol) 
  independently predicted the d-ROM value, that d-ROM 
levels were positively correlated with hs-CRP levels and 
inversely correlated with the flow-mediated dilation value, Vascular Health and Risk Management 2011:7
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and that subjects with high levels of both d-ROM and   hs-CRP 
had significantly reduced flow-mediated dilation values 
compared with subjects with low levels of both markers 
of oxidative stress and inflammation. These findings show 
that d-ROM is a useful biomarker for detecting endothelial 
dysfunction, and is thus a surrogate marker of vascular failure 
and cardiovascular events. To the best of our knowledge, 
this is the first study that demonstrates a significant and 
close relationship between d-ROM and vascular function. 
High levels of d-ROM, especially combined with high 
hs-CRP, seem to indicate a significant deterioration of 
endothelial function.
Oxidative stress associated with and/or derived from 
cardiovascular risk factors, including dyslipidemia, hyper-
tension, and smoking, is implicated in the pathogenesis of 
vascular damage and contributes to the development of 
atherosclerosis.6,7,16 However, a marker of oxidative stress 
suitable for assessment of early-stage atherosclerosis has not 
been established. The present study demonstrated a signifi-
cant association between d-ROM and several conventional 
cardiovascular risk parameters in the general population, 
suggesting that the d-ROM level reflects total cardiovas-
cular risk in individuals. Furthermore, endothelial function 
progressively deteriorated with increasing d-ROM levels in 
subjects with mild-to-moderate cardiovascular risk. Similar 
flow-mediated dilation values in the first and second tertiles 
of d-ROM in study 2 suggest that there is a threshold at which 
oxidative stress causes detectable endothelial dysfunction. 
Alternatively, the results may reflect the concept that the 
endothelial function is determined not only by offending 
endothelial factors, such as oxidative stress, but also by the Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
Dovepress 
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balance between offending and defending factors. Because 
subjects in study 2 were assumed to have subclinical athero-
sclerosis, d-ROM may be a sensitive marker of endothelial 
damage induced by oxidative stress in the early stages of 
atherosclerosis. On the other hand, markers of oxidized 
modification of lipid components are useful, particularly 
for the assessment of advanced atherosclerosis.29 Indeed, the 
malondialdehyde-modified low-density lipoprotein level has 
been shown to be increased independently of low-density 
lipoprotein cholesterol levels in patients with coronary artery 
disease, especially in patients with unstable plaques.30–32
Although we did not compare the clinical value of d-ROM 
with other oxidative stress markers, the demonstrated close 
correlation of d-ROM and hs-CRP, an established predictor 
of cardiovascular events,17,21,22 suggested it to be a reliable 
marker for cardiovascular risk assessment. Because d-ROM 
and hs-CRP are fundamentally different in nature, the mea-
surements of these two markers may be complementary. 
Indeed, measuring a combination of d-ROM and hs-CRP 
would provide powerful and useful information in subjects 
with concealed high risk, because an increase in both hs-
CRP and d-ROM levels, but not in either of the markers, 
predicts definite endothelial dysfunction in subjects with 
mild-to-moderate cardiovascular risk. In this context, both 
d-ROM and hs-CRP are suitable for screening of individual 
cardiovascular risk in early-stage atherosclerosis.
The present results demonstrated that d-ROM was inde-
pendently correlated with brain natriuretic peptide as well as 
classical cardiovascular risk factors. Because brain natriuretic 
peptide is broadly accepted as a predictor of cardiac function, 
cardiac load, and cardiac events,33,34 our findings indicate 
that oxidative stress is closely associated with functional 
and structural alteration of the heart. Accumulation of car-
diovascular risk may affect the circulatory system including 
the vasculature and heart through an increase in oxidative 
stress, and d-ROM may reflect these changes.
Recently, several studies have confirmed a significant 
correlation between the number and activity of circulating 
endothelial progenitor cells and endothelial function.26–28 In 
one study, a reduction in circulating endothelial progenitor 
cell number was associated with an increased risk of cardio-
vascular disease.27 In the present study, the number of CD34+ 
progenitor cells was correlated with the flow-mediated dila-
tion value, but not with d-ROM. Assessment of other cell 
fractions or function, such as migration, proliferation, and 
antioxidant properties, may be essential for evaluating circu-
lating endothelial progenitor cells, although the complicated 
and specialized investigations needed might not be amenable 
to use in the clinical setting.26,28
The present study had several limitations. First, sample 
size for the evaluation of endothelial function was small, 
and heterogeneity in background of the subjects may have 
affected the results. Further study with increased subject 
numbers is therefore needed to provide a definitive con-
clusion. Second, the impact of smoking, one of the most 
important risk factors, on d-ROM was not assessed in the 
general population (study 1). Third, although patients with 
the smoking habit in study 2 were instructed to stop smok-
ing 24 hours before the examination, it has not been estab-
lished that the acute effects of smoking disappeared within 
24 hours. Fourth, observed correlations between d-ROM 
and endothelial function or other variables do not necessary 
mean causal relationships, and the predictive value of the 
index of oxidative stress could not be evaluated in the present 
cross-sectional study. Fifth, we could not identify the source 
of oxidative stress measured by d-ROM. Further biological 
assessments to elucidate the underlying mechanisms and 
interventional studies are necessary to confirm the clinical 
significance of the index.
In conclusion, increased oxidative stress evaluated by 
d-ROM was significantly associated with cardiovascular risk 
factors, systemic inflammation, and endothelial dysfunction. 
Assessment of d-ROM, which is easy to measure without any 
technical complexity, is a useful and reliable way to detect 
concealed endothelial damage in the clinical setting and may 
be a powerful predictor of cardiovascular disease.
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the d-ROM level (cutoff level is 316 carr, mean value) and the hs-cRP level [cutoff 
level is 0.50 mg/L, corresponding to the mean value of log (hs-cRP)]. Data are 
expressed as means ± standard deviation.Vascular Health and Risk Management
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